Ushbu ish iqtibos qilgan ishlar

55 ta ish

Ish: Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

1. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

   Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo +11

   Maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.296917

2. FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma

   John Reiser, Szeman Ruby Chan, Ketan Mathavan +16

   Maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.296918

3. Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

   Zhuoxiao Cao, Cuiqing Yang, Yifang Wang +9

   Maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.296919

4. Anti-BCMA-CAR NK Cells Expressing Soluble TRAIL: Promising Therapeutic Approach for Multiple Myeloma in Combination with Bortezomib and γ-Secretase Inhibitors

   Benjamin Motais, Sandra Charvátová, Matouš Hrdinka +2

   Maqola20222 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.296921

5. Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer

   Xin Zhang, Zheng Xu, Xiangpeng Dai +2

   Sharh maqola20232 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.296924